Appeals Court Upholds Patent Ruling in DNA Case

The U.S. Court of Appeals last week upheld a decision from the Northern District of California in a case involving patent protection for a fetal DNA extraction and diagnosing process. The court ruled that the scientific process closely resembles a natural process and therefore isn’t eligible for patent protection—a decision that is good for biotech companies researching genetic sequences, according to Intellectual Property partner Richard Blaylock.